Candel Therapeutics (CADL) Cash & Equivalents (2020 - 2026)
Candel Therapeutics (CADL) reported Cash & Equivalents of $201.57 million for Q2 2026, up 100.2% from $100.69 million a year earlier.
Powered by 
Analysis
Candel Therapeutics (CADL) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Candel Therapeutics posted Cash & Equivalents of $119.73 million, up 16.6% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of 27.8% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $102.65 million in FY2024 (+189.9%), $35.41 million in FY2023 (-49.5%), $70.06 million in FY2022 (-15.2%) and $82.64 million in FY2021 (+135.8%).
- The Q2 2026 figure ranks as the highest quarterly Cash & Equivalents in data going back to Q4 2020.
- Year over year, Cash & Equivalents gained in six of the last seven quarters, with growth averaging 185.1%.
- The high point for year-over-year Cash & Equivalents in five years was Q3 2025 (growth of 423.9%); the low point was Q3 2024 (a decline of 61.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Candel Therapeutics | 774.88 Mn | 774.88 Mn | - | 201.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 201.57 Mn |
| Dec 31, 2025 | 119.73 Mn |
| Sep 30, 2025 | 86.96 Mn |
| Jun 30, 2025 | 100.69 Mn |
| Mar 31, 2025 | 92.17 Mn |
| Dec 31, 2024 | 102.65 Mn |
| Sep 30, 2024 | 16.60 Mn |
| Jun 30, 2024 | 21.50 Mn |
| Mar 31, 2024 | 25.71 Mn |
| Dec 31, 2023 | 35.41 Mn |
| Sep 30, 2023 | 43.00 Mn |
| Jun 30, 2023 | 51.90 Mn |
| Mar 31, 2023 | 59.26 Mn |
| Dec 31, 2022 | 70.06 Mn |
| Sep 30, 2022 | 77.18 Mn |
| Jun 30, 2022 | 86.78 Mn |
| Mar 31, 2022 | 94.32 Mn |
| Dec 31, 2021 | 82.64 Mn |
| Sep 30, 2021 | 88.39 Mn |
| Jun 30, 2021 | 24.32 Mn |
API Access
Candel Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CADL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "CADL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CADL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();